AI is about to change healthcare. These 30 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
To own Sopra Steria, you need to believe it can convert its strong position in European public and regulated sectors into steadier growth and better cash generation, despite recent organic revenue pressure and working capital strain. The appointment of Rajesh Krishnamurthy looks most relevant to the medium term, as his transformation experience could support margin and portfolio shifts, but it does not materially change the near term focus on stabilizing volumes and improving free cash flow.
Among recent developments, the go live of the eu LISA sBMS biometric platform underlines Sopra Steria’s role in high value, mission critical public sector systems, an area closely linked to its defense and security catalyst. This type of project underpins the investment case around more resilient, higher margin sovereign IT and provides a context in which an incoming CEO with large scale digital transformation experience might look to deepen the company’s positioning in complex, AI enabled services.
But investors should also be aware that persistent negative organic growth in core European markets could still...
Read the full narrative on Sopra Steria Group (it's free!)
Sopra Steria Group's narrative projects €6.1 billion revenue and €373.6 million earnings by 2028. This requires 2.7% yearly revenue growth and about a €91.6 million earnings increase from €282.0 million today.
Uncover how Sopra Steria Group's forecasts yield a €201.90 fair value, a 39% upside to its current price.
Seven fair value estimates from the Simply Wall St Community span about €98 to €254 per share, showing how far apart individual views can be. When you set that against concerns about persistent organic revenue contraction in key markets, it underlines why many investors may want to compare several independent opinions before deciding how Sopra Steria fits into their portfolio.
Explore 7 other fair value estimates on Sopra Steria Group - why the stock might be worth 32% less than the current price!
Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.
Our top stock finds are flying under the radar-for now. Get in early:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com